IMMUNE-MEDIATED HEPATITIS
Clinical trials for IMMUNE-MEDIATED HEPATITIS explained in plain language.
Never miss a new study
Get alerted when new IMMUNE-MEDIATED HEPATITIS trials appear
Sign up with your email to follow new studies for IMMUNE-MEDIATED HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Low-Dose steroid tame Immunotherapy's liver side effect?
Symptom relief Recruiting nowThis study looks at whether a low dose of the steroid prednisolone can effectively treat liver inflammation (hepatitis) that sometimes occurs as a side effect of cancer immunotherapy. About 63 cancer patients who develop moderate to severe liver inflammation from their treatment …
Matched conditions: IMMUNE-MEDIATED HEPATITIS
Sponsor: University Hospital, Basel, Switzerland • Aim: Symptom relief
Last updated May 06, 2026 16:04 UTC
-
Blood test could tell immunotherapy hepatitis apart from other liver inflammation
Knowledge-focused Recruiting nowThis study aims to find specific blood markers that can tell the difference between hepatitis caused by immune checkpoint inhibitors (a type of cancer immunotherapy) and other forms of autoimmune hepatitis. Researchers will compare blood samples from 60 adults with immunotherapy-…
Matched conditions: IMMUNE-MEDIATED HEPATITIS
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated May 17, 2026 04:14 UTC
-
New study aims to uncover hidden liver risks of immunotherapy drugs
Knowledge-focused Recruiting nowThis study looks at liver injury caused by checkpoint inhibitor drugs used in cancer treatment. Researchers will follow 160 people to find out how common this side effect is and what makes some people more likely to get it. They will also test blood samples for new markers that c…
Matched conditions: IMMUNE-MEDIATED HEPATITIS
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated May 12, 2026 13:39 UTC